Efficacy of atezolizumab with concomitant radiotherapy in patients with musculo-invasive bladder cancer. ML40458
INDEPENDENT CLINICAL TRIAL
Clinical trial information
- Promoter: SPANISH GENITOURINARY ONCOLOGY GROUP (SOGUG)
- Phase: II
- Execution start: 17/01/2020
- End of execution: 30/10/2026
- IP: